Chronic exposure to perfluorinated compounds: Impact on airway hyperresponsiveness and inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 307, Issue 10, 2014, Pages L765-L774

  Ryu, Min H ^a,b   Jha, Aruni ^a,b   Ojo, Oluwaseun O ^a,b   Mahood, Thomas H ^a,b   Basu, Sujata ^a,b   Detillieux, Karen A ^a,b   Nikoobakht, Neda ^a,c   Wong, Charles S ^a,c   Loewen, Mark ^b   Becker, Allan B ^a,b   Halayko, Andrew J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

^c UNIVERSITY OF WINNIPEG   (Canada)

Author keywords

Asthma; Environmental pollutant; Interferon ; Perfluorooctanoic acid; Perflurooctanesulfonic acid

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; OVALBUMIN; PERFLUORO COMPOUND; PERFLUOROOCTANOIC ACID; PERFLUROOCTANESULFONIC ACID; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; AIR POLLUTANT; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS; CELL COUNT; CONTROLLED STUDY; DISEASE EXACERBATION; FEEDING; FEMALE; GESTATIONAL AGE; GOBLET CELL; HEPATOMEGALY; INFLAMMATORY CELL; LEUKOCYTE; LONG TERM EXPOSURE; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG INFILTRATE; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUP (RODENT); RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; WEIGHT GAIN; AIR POLLUTANT; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; IMMUNOLOGY; LUNG; PATHOLOGY; PREGNANCY; TOXICITY;

AIR POLLUTANTS; ALKANESULFONIC ACIDS; ANIMALS; ASTHMA; CAPRYLATES; FEMALE; FLUOROCARBONS; GOBLET CELLS; INTERFERON-GAMMA; LUNG; MATERNAL EXPOSURE; MICE; MICE, INBRED BALB C; PREGNANCY;

EID: 84925223176     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00100.2014     Document Type: Article

References (39)

1. Anderson-Mahoney P, Kotlerman J, Takhar H, Gray D, Dahlgren J. Self-reported health effects among community residents exposed to perfluorooctanoate. J Environ Occup Health Policy 18: 129-143, 2008.
2. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115: 1670-1676, 2007.
3. Arai N, Kondo M, Izumo T, Tamaoki J, Nagai A. Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur Resp J 35: 1164-1171, 2010.
4. Belvisi MG, Mitchell JA. Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease (Abstract). Br J Pharmacol 158: 809164, 2009.
5. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 111: 559- 564, 2011.
6. DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39: 76-94, 2009.
7. Dong GH, Tung KY, Tsai CH, Liu MM, Wang D, Liu W, Jin YH, Hsieh WS, Lee YL, Chen PC. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of taiwanese children. Environ Health Perspect 121: 507-513, 2013.
8. D'Hollander W, Voogt P, Coen W, Bervoets L. Perfluorinated substances in human food and other sources of human exposure. In: Reviews of Environmental Contamination and Toxicology. New York, NY: Springer, 2010, p. 179-215.
9. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48: 759-770, 2006.
10. Fairley KJ, Purdy R, Kearns S, Anderson SE, Meade B. Exposure to the immunosuppresant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. Toxicol Sci 97: 375- 383, 2007.
11. Gosetti F, Chiuminatto U, Zampieri D, Mazzucco E, Robotti E, Calabrese G, Gennaro MC, Marengo E. Determination of perfluorochemicals in biological, environmental and food samples by an automated on-line solid phase extraction ultra high performance liquid chromatography tandem mass spectrometry method. J Chromatogr A 1217: 7864- 7872, 2010.
12. Grasty RC, Bjork JA, Wallace KB, Lau CS, Rogers JM. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defect Res B 74: 405-416, 2005.
13. Grasty RC, Grey BE, Lau CS, Rogers JM. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defect Res B 68: 465-471, 2003.
14. Haug LS, Huber S, Schlabach M, Becher G, Thomsen C. Investigation on per- and polyfluorinated compounds in paired samples of house dust and indoor air from Norwegian homes. Environ Sci Technol 45: 7991- 7998, 2011.
15. Haug LS, Thomsen C, Becher G. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J Chromatogr A 1216: 385-393, 2009.
16. Heuvel JPV, Thompson JT, Frame SR, Gillies PJ. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: A comparison of human, mouse, and rat Peroxisome Proliferator- Activated Receptor- α, - β, and - γ, Liver X Receptor- β, and Retinoid X Receptor. Toxicol Sci 92: 476-489, 2006.
17. Hinderliter PM, Mylchreest E, Gannon SA, Butenhoff JL, Kennedy GL, Jr. Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 211: 139-148, 2005.
18. Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: a review. Domestic Animal Endocrinology 22: 1-23, 2002.
19. Irvin CG, Bates JH. Measuring the lung function in the mouse:the challenge of size (Abstract). Respir Res 4: 4, 2003.
20. Kennedy GL, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG. The toxicology of perfluorooctanoate. Crit Rev Toxicol 34: 351-384, 2004.
21. Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, Kim S, Park S, Hwang I, Jeon J, Yang H, Giesy JP. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol 45: 7465-7472, 2011.
22. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99: 366-394, 2007.
23. Lau C, Butenhoff JL, Rogers JM. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198: 231-241, 2004.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT. Method 25: 402-408, 2001.
25. Llorca M, Farré M, Picó Y, Müller J, Knepper TP, Barceló D. Analysis of perfluoroalkyl substances in waters from Germany and Spain. Sci Total Environ 431: 139-150, 2012.
26. Midoro-Horiuti T, Tiwari R, Watson CS, Goldblum RM. Maternal bisphenol A exposure promotes the development of experimental asthma in mouse pups. Environ Health Perspect 118: 273-277, 2009.
27. Mosch C, Kiranoglu M, Fromme H, Völkel W. Simultaneous quantitation of perfluoroalkyl acids in human serum and breast milk using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. J Chromatogr B 878: 2652-2658, 2010.
28. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR. Half-Life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115: 1298-1305, 2007.
29. Olsen GW, Lange CC, Ellefson ME, Mair DC, Church TR, Goldberg CL, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Reagen WK, Zobel LR. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environ Sci Technol 46: 6330-6338, 2012.
30. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, Libby P. Interferon-γ, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circ Res 103: 467-476, 2008.
31. Schoenborn JR, Wilson CB. Regulation of interferon-γ during innate and adaptive immune responses. Advan Immunol 96: 41-101, 2007.
32. Shoeib M, Harner T, Webster G M, Lee SC. Indoor sources of polyand perfluorinated compounds (PFCS) in Vancouver, Canada: implications for human exposure. Environ Sci Technol 45: 7999-8005, 2011..
33. Singh TSK, Lee S, Kim HH, Choi JK, Kim SH. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. Toxicol Lett 210: 64-70, 2012.
34. Stahl T, Mattern D, Brunn H. Toxicology of perfluorinated compounds (Abstract). Environ Sci Eur 23: 38, 2011.
35. Stock NL, Lau FK, Ellis DA, Martin JW, Muir DCG, Mabury SA. Polyfluorinated telomer alcohols and sulfonamides in the North American troposphere. Environ Sci Technol 38: 991-996, 2004.
36. Tittlemier SA, Pepper K, Seymour C, Moisey J, Bronson R, Cao XL, Dabeka RW. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 55: 3203-3210, 2007.
37. Tomioka S, Bates J, Irvin CG. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol 93: 263-270, 2002.
38. USEPA. 2010/2015 PFOA Stewardship Program [Online]. US Environmental Protection Agency. http://www.epa.gov/opptintr/pfoa/pubs/ stewardship/index.html [21 Jan. 2014].
39. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, atherosclerosis. Immunol Rev 219: 187-203, 2007.